First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

NCT03625037 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

666

Enrollment

INDUSTRY

Sponsor class

Conditions

DLBCL
High-grade B-cell Lymphoma (HGBCL)
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
FL
MCL
Small Lymphocytic Lymphoma (SLL)
Marginal Zone Lymphoma (MZL)
Indolent B-cell Non-Hodgkin Lymphoma (iNHL)
Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)

Interventions

BIOLOGICAL: Epcoritamab

Sponsor

Genmab

Collaborators

[object Object]